Coalition Says Bayh-Dole Not For Cutting Drug Costs

The branded-drug industry, top research universities and other organizations on Thursday said they've banded together to return the Bayh-Dole Act to its original purpose, which they say is expanding innovation and...

Already a subscriber? Click here to view full article